Distinction of desmoplastic melanoma from non-desmoplastic melanoma by gene expression profiling

Journal of Investigative Dermatology

Volumn 124, Issue 2, 2005, Pages 412-419

  Busam, Klaus J ^a,c   Zhao, Hui ^a   Coit, Daniel G ^a   Kucukgol, Derya ^a   Jungbluth, Achim A ^b   Nobrega, Jennifer ^a   Viale, Agnes ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^c NONE   (United States)

Author keywords

Clusterin; Desmoplasia; Gene expression profiling; Melanoma

Indexed keywords

CLUSTERIN; NEUROTROPHIC FACTOR; OLIGONUCLEOTIDE;

ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; EXTRACELLULAR MATRIX; GENE CONTROL; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MELANOMA; PRIORITY JOURNAL; RECURRENT DISEASE; SPINDLE CELL; UPREGULATION;

EID: 12944280986     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.23600.x     Document Type: Article

References (44)

1. Alizadeh AA, Ross DT, Perou CM, van de Rijn M: Towards a novel classification of human malignancies based on gene expression patterns. J Pathol 195:41-52, 2001
2. Baer SC, Schultz D, Synnestvedt M, Elder DE: Desmoplasia and neurotropism. Prognostic variables in patients with stage I melanoma. Cancer 76:2242-2247, 1995
3. Blaschuk O, Burdzy K, Fritz IB: Purification and characterization of a cell-aggregating factor (clusterin), the major glycoprotein in ram testis fluid. J Biol Chem 258:7714-7720, 1983
4. Blesch A, Tuszynski MH: Cellular GDNF delivery promotes growth of motor and dorsal column sensory axons after partial and complete spinal cord transactions and induces remyelination. J Comp Neurol 467:403-417, 2003
5. Bou Gharios G, Osman J, Black C, Olsen I: Excess matrix accumulation in scleroderma is caused partly by differential regulation of stromelysin and TIMP-1 synthesis. Clin Chim Acta 231:69-78, 1994
6. Busam KJ, Chen YT, Old LJ, et al: Expression of melan-A (MART-1) in benign melanocytic nevi and primary cutaneous malignant melanoma. Am J Surg Pathol 22:976-982, 1998
7. Busam KJ, Iversen K, Coplan KC, Jungbluth AA: Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma. Am J Surg Pathol 25:197-204, 2001
8. Busam KJ, Mujumdar U, Hummer A, Nobrega J, Hawkins WG, Coit DG, Brady MS: Cutaneous desmoplastic melanoma: Re-appraisal of phenotypic heterogeneity and prognostic factors. Am J Surg Pathol 28:1518-1525, 2004
9. Carlson JA, Dickersin GR, Sober AJ, Barnhill RL: Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases. Cancer 75:478-494, 1995
10. Conley J, Lattes R, Orr W: Desmoplastic malignant melanoma (a rare variant of pindle cell melanoma). Cancer 28:914-936, 1971
11. Daimaru Y, Hashimoto H, Enjoji M: Malignant peripheral nerve sheath tumors (malignant schwannomas). An immunohistochemical study of 29 cases. Am J Surg Pathol 9:434-444, 1985
12. Egbert E, Kempson R, Sagebiel R: Desmoplastic malignant melanoma: A clinicopathologic study of 25 cases. Cancer 62:2033-2041, 1988
13. Fikuda M, Kuroda TS, Mikoshiba K: Slac2-a/melanophilin, the missing link between Rab27 and Myosin Va. J Biol Chem 277:12432-12436, 2002
14. Guyonneau L, Murisier F, Rossier A, Moulin A, Beermann F: Melanocytes and pigmentation are affected in dopachrome tautomerase knockout mice. Mol Cell Biol 24:3396-3403, 2004
15. Gyorki DE, Busam K, Panageas K, Brady MS, Coit DG: Sentinel lymph node biopsy for patients with cutaneous desmoplastic melanoma. Ann Surg Oncol 10:403-407, 2003
16. Iwamoto S, Burrows RC, Agoff SN, Piepkorn M, Bothwell M, Schmidt R: The 75 neurotrophin receptor, relative to other Schwann cell and melanoma markers, is abundantly expressed in spindled melanoma. Am J Dermatopathol 23:288-294, 2001
17. Jain S, Allen PW: Desmoplastic malignant melanoma and its variants. Am J Surg Pathol Am J Surg Pathol 13:358-373, 1989
18. Jaroswewski DE, Pockaj BA, DiGaudo DJ, Bite U: The clinical behavior of desmoplastic melanoma. Am J Surg 182:590-595, 2001
19. Jones SE, Jomary C: Clusterin. Int J Biochem Cell Biol 34:427-431, 2002
20. Jungbluth AA, Iversen K, Coplan K, et al: T311 - an antityrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues. Pathol Res Pract 196:235-242, 2000
21. Kadomatsu K, Muramatsu T: Midkine and pleiotrophin in neural development and cancer. Cancer Lett 204:127-143, 2004
22. Kanik AN, Yaar M, Bhawan J: p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma. J Cutan Pathol 23:205-210, 1996
23. King R, Busam K, Rosai J: Metastatic malignant melanoma resembling malignant peripheral nerve sheath tumor: A report of 16 cases. Am J Surg Pathol 23:1499-1505, 1999
24. Koch MB, Shih IM, Weiss SW, Folpe AL: Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics. Am J Surg Pathol 25:58-64, 2001
25. Krengel S, Alexander M, Brinckmann J, Tronnier M: MMP-2, TIMP-2 and MT1-MMP are differentially expressed in lesional skin of melanocytic nevi and their expression is modulated by UV-light. J Cutan Pathol 29:390-396, 2002
26. Kubo M, Kikuchi K, Nashiro K, Kakinuma T, Hayashi N, Nanko H, Tamaki K: Expression of fibrogenic cytokines in desmoplastic malignant melanoma. Br J Dermatol 139:192-197, 1998
27. Leskov KS, Klokov DY, Li J, Kinsella TJ, Boothman DA: Synthesis and functional analyses of nuclear clusterin, a cell death protein. J Biochem 278:11590-11600, 2003
28. Matsuda A, Itoh Y, Koshikawa N, Akizawa T, Yana L, Seiki M: Clusterin, an abundant serum factor, is a possible negative regulator of MT6 MMP/MMP-25 produced by neutrophils. J Biol Chem 278:36350-36357, 2003
29. Pucci S, Bonanno E, Pichiorri F, Angeloni C, Spagnoli LG: Modulation of different clusterin isoforms in human colon tumorigenesis. Oncogene 23:2298-2304, 2004
30. Quinn MJ, Crotty KA, Thompson JF, Coates AS, O'Brien CJ, McCarthy WH: Desmoplastic and desmoplastic neurotropic melanoma: Experience with 280 patients. Cancer 83:1128-1135, 1998
31. Robson A, Allen P, Hollowood K: S100 expression in cutaneous scars: A potential diagnostic pitfall in the diagnosis of desmoplastic melanoma. Histopathology 38:135-140, 2001
32. Sadlier DM, Connolly SB, Kieran NE, et al: Sequential extracellular matrix-focused and baited-global cluster analysis of serial transcriptomic profiles identifies candidate modulators of renal tubulointerstitial fibrosis in murine adriamycin induced nephropathy. J Biol Chem 279:29670-29680, 2004
33. Saffer H, Wahed A, Rassidakis GZ, Medeiros J: Clusterin expression in malignant lymphomas: A survey of 266 cases. Mod Pathol 15:1221-1226, 2002
34. Scaltriti M, Brausi M, Amorosi A, et al: Clusterin (SGP-2, ApoJ) expression is downregulated in low- and high-grade human cancer. Int J Cancer 108:23-30, 2004
35. Schiaffino MV, Baschirotto C, Pellegrini G, Montalti S, Tacchetti C, De Luca M, Ballabio A: The ocular albinism type 1 gene product is a membrane glycoprotein localize to melanosomes. Proc Natl Acad Sci USA 93:9055-9060, 1996
36. Segal NH, Pavlidis P, Noble WS, et al: Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling. J Clin Oncol 9:1775-1781, 2003
37. Seykora JT, Jih D, Elenitsas R, Horng WH, Elder DE: Gene expression profiling of melanocytic lesions. Am J Dermatopathol 25:6-11, 2003
38. Shen B, Orlow SJ: The ocular albinism type 1 gene product is an N-glycoprotein but glycosylation is not required for its subcellular distribution. Pigment Cell Res 14:485-490, 2001
39. Skelton HG, Smith KL, Laskin WB, McCarthy WF, Gagnier JM, Graham JH, Lupton GP: Desmoplastic malignant melanoma. J Am Acad Dermatol 32:717-725, 1995
40. Smithers BM, McLeod GR, Little JH: Desmoplastic, neural transforming and neurotropic melanoma: A review of 45 cases. Aust NZ J Surg 60:967-972, 1990
41. Staudt LM: Molecular diagnosis of hematologic cancers. N Engl J Med 348:1777-1785, 2003
42. Thelmo MC, Sagebiel RW, Treseler PA, Morita ET, Nguyen LH, Kashani-Sabet M, Leong SP: Evaluation of sentinel lymph node status in spindle cell melanomas. J Am Acad Dermatol 44:451-455, 2001
43. Troxel DB: Pitfalls in the diagnosis of malignant melanoma: Findings of a risk management panel study. Am J Surg Pathol 27:1278-1283, 2003
44. Winnepennickx V, De Vos R, Stas M, van den Oord JJ: New phenotypical and ultrastructural findings in spindle cell (desmoplastic/neurotropic) melanoma. Appl Immunohistochem Mol Morphol 11:319-325, 2003